Ipsen’s partner Exelixis announces clinical collaboration with Bristol Myers Squibb for late-stage combination trial in first-line renal cell carcinoma.

David Loew joins Ipsen as CEO

One year later: How are we doing with our Environmental, Social and Governance (ESG) criteria for external financing?

Ipsen Alliance Management Team Receives Prestigious 2020 ASAP Award of Excellence for Long-term Established Partnerships

ASCO 2020: A virtual success